Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome

被引：3
|
作者：
Souied, Eric H. [1 ]
Cohen, Salomon-Yves [2 ]
de Pouvourville, Gerard [3 ]
Dupeyron, Gerard [4 ]
Latour, Elisabeth [5 ]
Ponthieux, Anne [5 ]
Weber, Michel [6 ]
机构：
[1] UPEC, Creteil Univ Eye Clin, Interc Hosp Creteil, Creteil, France
[2] Ophthalm Ctr Laser & Med Imagery, Paris, France
[3] ESSEC, Cergy Pontoise, France
[4] Univ Nimes Hosp, Dept Ophthalmol, F-30006 Nimes, France
[5] Novartis Pharma SAS, Rueil Malmaison, France
[6] Hotel Dieu Univ Hosp, Dept Ophthalmol, Nantes, France
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷 / 02期
关键词：
DISEASE;
D O I：
10.1111/aos.12517
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E179 / E180
页数：2
相关论文
共 50 条
  • [41] Clinical outcome of switching from ranibizumab to aflibercept in the treatment of neovascular age-related macular degeneration
    Lu, Lin
    Muthulingam, Gnanaruban
    Osborne, Claire
    Tonne, Prabhu
    Reddy, Gopinath
    Logendran, Maharatnam
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [42] Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab
    Sabour-Pickett, Sarah
    Loughman, James
    Nolan, John M.
    Stack, Jim
    Pesudovs, Konrad
    Meagher, Katherine A.
    Beatty, Stephen
    JOURNAL OF OPHTHALMOLOGY, 2013, 2013
  • [43] Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
    Stoller, Glenn L.
    Kokame, Gregg T.
    Dreyer, Richard F.
    Shapiro, Howard
    Tuomi, Lisa L.
    JAMA OPHTHALMOLOGY, 2016, 134 (05) : 545 - 553
  • [44] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
  • [45] Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
    Gamulescu M.-A.
    Radeck V.
    Lustinger B.
    Bianca Fink B.
    Helbig H.
    International Ophthalmology, 2010, 30 (3) : 261 - 266
  • [46] Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab
    Kanoff, Justin
    Miller, Joan
    SEMINARS IN OPHTHALMOLOGY, 2013, 28 (5-6) : 355 - 360
  • [47] Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration
    Doguizi, Sibel
    Ozdek, Sengul
    Yuksel, Selcen
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (04) : 846 - 848
  • [48] Recent Developments in the Treatment of Wet Age-related Macular Degeneration
    Papadopoulos, Zois
    CURRENT MEDICAL SCIENCE, 2020, 40 (05) : 851 - 857
  • [49] Hypertension affects the treatment of wet age-related macular degeneration
    Wang, Ting
    Xia, Jun
    Yuan, Meng
    Wu, Xiaohang
    Zhu, Yi
    Chen, Chuan
    Bergunder, Sean J.
    Liu, Zhenzhen
    Chen, Wenben
    Huang, Kai
    Lin, Haotian
    ACTA OPHTHALMOLOGICA, 2021, 99 (08) : 871 - 876
  • [50] Controversies in the treatment of wet age-related macular degeneration - Reply
    Bashshur, Ziad F.
    Haddad, Zeina A.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (05) : 938 - 938
12345